Alpha Teknova, Inc. logo

Alpha Teknova, Inc. (TKNO)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
4. 80
-0.03
-0.62%
$
250.52M Market Cap
- P/E Ratio
0% Div Yield
166,461 Volume
-0.77 Eps
$ 4.83
Previous Close
Day Range
4.54 4.81
Year Range
3.94 10.37
Want to track TKNO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TKNO closed Friday lower at $4.8, a decrease of 0.62% from Thursday's close, completing a monthly increase of 6.43% or $0.29. Over the past 12 months, TKNO stock lost -41.75%.
TKNO is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2025, exceeded the consensus estimates by 0.02%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

TKNO Chart

Similar

QSG
Here Group Limited
$ 5.41
+5.25%
NIU
Niu Technologies
$ 3.21
-8.02%
Microvision Inc.
$ 0.92
-0.65%
Rci Hospitality Holdings Inc.
$ 26.02
-1.03%
1stdibs.com, Inc.
$ 6.08
-1.78%
Alpha Teknova, Inc. (TKNO) Q2 2025 Earnings Call Transcript

Alpha Teknova, Inc. (TKNO) Q2 2025 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Matthew C. Lowell - Chief Financial Officer Stephen Gunstream - President, CEO & Director Conference Call Participants Brendan Mychal Smith - TD Cowen, Research Division Matthew Moriarty Parisi - KeyBanc Capital Markets Inc., Research Division Matthew Richard Larew - William Blair & Company L.L.C.

Seekingalpha | 4 months ago
Alpha Teknova, Inc. (TKNO) Q1 2025 Earnings Call Transcript

Alpha Teknova, Inc. (TKNO) Q1 2025 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2025 Results Conference Call May 8, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President, Marketing Stephen Gunstream - President and Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Anna Snopkowski - KeyBanc Matt Hewitt - Craig-Hallum Capital Group Matt Larew - William Blair Chad Wiatrowski - TD Cowen Operator Good day, and thank you for standing by. Welcome to the Teknova First Quarter 2025 Financial Results Conference Call.

Seekingalpha | 7 months ago
Alpha Teknova, Inc. (TKNO) Q4 2024 Earnings Call Transcript

Alpha Teknova, Inc. (TKNO) Q4 2024 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2024 Earnings Call March 4, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President, Marketing Stephen Gunstream - President and Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Matthew Parisi - KeyBanc Capital Markets Mark Massaro - BTIG Matt Hewitt - Craig-Hallum Operator Thank you for standing by, and welcome to Teknova's Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Jennifer Henry, Senior Vice President of Marketing.

Seekingalpha | 9 months ago

Alpha Teknova, Inc. (TKNO) FAQ

What is the stock price today?

The current price is $4.80.

On which exchange is it traded?

Alpha Teknova, Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is TKNO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 250.52M.

Has Alpha Teknova, Inc. ever had a stock split?

No, there has never been a stock split.

Alpha Teknova, Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Stephen Gunstream CEO
NASDAQ (NMS) Exchange
02080L102 CUSIP
US Country
173 Employees
- Last Dividend
- Last Split
25 Jun 2021 IPO Date

Overview

Alpha Teknova, Inc. is a company that plays a significant role in the life sciences sector, offering a broad range of critical reagents crucial for the research, discovery, development, and commercialization of innovative therapies, vaccines, and molecular diagnostics both in the domestic and international markets. Since its inception in 1996, the company has established a substantial presence, headquartered in Hollister, California, and has become a trusted supplier to the pharmaceutical and biotechnology industries, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. is dedicated to supporting the life sciences market by providing high-quality, reliable products essential for the advancement of medical science and healthcare.

Products and Services

  • Pre-poured Media Plates - These are essential for cell growth and cloning applications, offering a sterile and convenient solution for researchers conducting cell culture experiments. The pre-poured media plates simplify the preparation process, ensuring consistency and reliability in results.
  • Liquid Cell Culture Media and Supplements - Alpha Teknova, Inc. provides a wide range of liquid cell culture media and supplements, which are crucial for the cellular expansion of various cell types. These products help in maintaining the optimal growth conditions, thereby facilitating successful culturing of cells for research and therapeutic use.
  • Molecular Biology Reagents - The company offers a comprehensive suite of molecular biology reagents required for sample manipulation, resuspension, and purification. These reagents are vital for analyzing and isolating nucleic acids and proteins, thereby playing a crucial role in molecular biology research and diagnostic test developments.
  • Lab Essentials - Alpha Teknova, Inc. provides a variety of chemical formulations that are extensively used in biological research and drug discovery efforts. These lab essentials are crucial for various experimental protocols and processes, assisting scientists in achieving accurate outcomes in their research endeavors.
  • Clinical Solutions - Offering custom products tailored for the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits, Alpha Teknova, Inc. caters to the critical needs of clinical development. These clinical solutions are designed to support the seamless transition from research to therapeutic application, ensuring the delivery of innovative treatments and diagnostic approaches.

Contact Information

Address: 2290 Bert Drive
Phone: 831 637 1100